CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- 4 Open-market buy President and CEO bought 10,000 shares at $3.00 ($29,987)
- 4 Open-market sale 10% owner sold 1,341,499 shares at $3.31 ($4,442,776)
- 4 Open-market buy President and CEO bought 5,000 shares at $3.02 ($15,104)
- 4 Open-market buy Chief Financial Officer bought 16,000 shares at an average $3.12 ($49,862)
- 4 Open-market buy Director bought 10,000 shares at $2.99 ($29,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 5,564 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Returned to the company Director returned 4,424 shares (to the company)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 14 · 273 filings